The richest man starts with black technology

(already edited)

First-class academic journals have an important influence factor in the academic world, and the profit method depends on the number of magazine subscriptions and the support of major academic research funds.

Third-rate academic journals will not have impact factors, nor will they have authoritative papers. They can only rely on publishing junk papers to make a living from the author’s bad money.

"Biological Science and Medical Technology" has been dealing with this kind of bad money for more than a decade.

But existence is reasonable. Although "Biological Science and Medical Technology" is bad, it also helps many students who need to evaluate professional titles and get graduation certificates, so that they can realize themselves even when they can't write in-depth papers. Small goal.

However, in the past few days, "Biological Science and Medical Technology" has changed its way of life.

Many universities, hospitals, and research institutions have purchased "Biological Science and Medical Technology". Although they only ordered the issue of Origin Technology's published papers, it was also a very good start.

In academia, "Biological Science and Medical Technology" (hereinafter referred to as "Biomedicine") is known as the Eyes of Wisdom!

When the Western "Nature", "Cell" and domestic "Biological Science" and other major academic weekly magazines rejected the original science and technology papers, "Biomedicine" actually published it. Isn't this what is it?

The editor-in-chief Zhang Feng asked everyone to say how he discovered the original technology paper, how he made a case and decided to publish the paper.

The actual situation is that after Zhang Feng learned that the symbiotic protein was used to treat respiratory diseases, he realized that the special paper was actually published here.

It is different from Zhang Feng's Lian Se.

The headquarters of "Biological Science" magazine hired experts for reviewing papers (many of them are professionals from universities and research institutions), and re-examined the paper as if it had not been published.

In the end, the experts unanimously reached a conclusion.If you redeploy the time, the paper will still fail to be reviewed, and the reason is still too advanced, just like a rootless ping.

The experts discussed:

"It doesn't make any sense to discuss this issue now, because Huaxi and Origin Technology have succeeded in clinical trials."

"In fact, I really want to go to Rongcheng to see those patients who have recovered after treatment, and use symbiotic green leaf protein to replace the lungs for breathing. I can't even think about it."

This is what everyone said during the meeting.

In fact, "Biological Science" is very regretful in its heart. If the original thinking was a little more active and published a paper on Origin Technology, it might establish the status of "Biological Science" as a domestic academic journal.

An expert in "Biological Sciences" commented: "Since the authenticity of the paper is clinically proven, this paper must have historical status in the medical and biological circles. It is a pity that we missed this opportunity."

Xia Guo's biomedical community is actively studying the papers and related experiments of the symbiosis photosynthetic chlorophyll of Origin Technology to replace the lungs to transport oxygen to the body and related experiments. This matter has also attracted great attention in Europe and the United States.

The New York Times, BBC and many other Western media based in Chengdu reported the news and called it an "impossible" experiment in order to verify it from the Western academic community.

The medical and biological circles in the West have also been paying attention to the development of Huaxi Hospital and technology these days, and were shocked by the clinical trials of symbiotic proteins.

The West has some doubts about how Xia Guoren, with poor high-end medical technology, solved the problems in the history of human medicine!

This not only solves the problem, but also creates a new biomedical direction for the future of mankind!

How can this be!

Why is the West the center of the world?

In addition to the brainwashing power of the people, the main thing is that the technology center is in the West.

The most important of all human science and technology centers is also basic science and technology.

These basic technologies include mathematics, physics, chemistry, biomedicine, etc.,

In terms of basic science, the West is absolutely in a leading position, and basic science and technology are absolutely leading, which means that the right to speak is leading.

The leadership of Western basic science and technology does not mean that Xia people are not good. In these basic science fields, Chinese people also have important contributions.

However, after the Chinese had learned it, they were affected by the huge siphon effect of the United States and Europe to the West, and they attributed their research results to the West. This is indeed a bit sad.

The monopoly of basic technology also means the monopoly of wealth.

Two very typical examples.

The first one is medical biology. The world's top medical institutions are in the United States, and the best pharmaceutical companies are also in the United States.

Most of Xia Guo's anti-cancer drugs are imported from the United States or Europe. The first thought of Xia Guo's wealthy people was to go to the United States for treatment.

Those targeted drugs that cost tens of thousands or more than 100,000 for a course of treatment come from Western pharmaceutical companies.

Because Xia Guo’s enterprises cannot produce them and their intellectual property rights are firmly in the hands of Westerners, they have a monopoly and are the only ones to sell you at high prices. It is not that I have developed and mastered the most fundamental core technology).

Second, the core technology of chips based on new physical materials and computers is also in the West.

Xia Guo spends trillions of dollars every year on the purchase of chips. The cost of importing chips far exceeds the cost of importing oil, and you must beg others and look at their faces when you buy.

There is no way, because the other party has a monopoly and you cannot produce it yourself.

Xia Guo's wealthiest private companies include BTA, most of which are engaged in the Internet and software, and dare not involve chips at all, because there is no technology and no talents.

Based on these preconditions, when Xia Guoren launched some disruptive biomedical technology, the first reaction in the West was suspicion!

In an interview with The New York Times, several professors of biomedicine from Stanford University, the most famous U.S. professor, refuted the research results of Origin Technology and called it impossible.

Middle of Stanford University is an expert in respiratory medicine. Ositinib, one of the most advanced lung cancer targeted drugs in the world, was developed by Middle's team in cooperation with AstraZeneca, UK.

The domestic price of Ositinib is about 16,000 boxes, and patients need to take one box a month. Many Xia Guo patients borrow money to take medicine and sell the house. In the end, the money is gone and no one is gone.

Every year, Midel's team receives generous remuneration from AstraZeneca, and part of these remunerations carry the blood of Xia Guo's patient.

Midel told reporters: "The treatment method of Origin Technology is absurd and unreasonable for Midel, and it is impossible to achieve. I do not comment on Xia Guo's academic environment, but I heard that Nature also rejected Xia Guo. That paper from, that says everything."